These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 32543800)

  • 21. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.
    Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial.
    Verburg A; Bor WL; Küçük IT; Henriques JPS; Vink MA; Ruifrok WT; Plomp J; Heestermans TACM; Schotborgh CE; Vlaar PJ; Magro M; Rikken SAOF; van den Broek WWA; van Mieghem CAG; Cornelis K; Rosseel L; Dujardin KS; Vandeloo B; Vandendriessche T; Ferdinande B; van 't Hof AWJ; Tijssen JGP; Limbruno U; De Caterina R; Rubboli A; Angiolillo DJ; Adriaenssens T; Dewilde W; Ten Berg JM
    EuroIntervention; 2024 Jul; 20(14):e898-e904. PubMed ID: 39007830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Kuno T; Ueyama H; Takagi H; Ando T; Numasawa Y; Briasoulis A; Fox J; Bangalore S
    Am J Cardiol; 2020 Feb; 125(4):521-527. PubMed ID: 31839147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
    Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study.
    De Luca L; Rubboli A; Bolognese L; Gonzini L; Urbinati S; Murrone A; Scotto di Uccio F; Ferrari F; Lucà F; Caldarola P; Lucci D; Gabrielli D; Di Lenarda A; Gulizia MM;
    BMJ Open; 2020 Dec; 10(12):e041044. PubMed ID: 33371033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double or Triple Antithrombotic Treatment in Atrial Fibrillation Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Benetou DR; Varlamos C; Mpahara A; Alexopoulos D
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):11-20. PubMed ID: 32170515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic treatment in atrial fibrillation patients undergoing PCI: Is dual therapy the winner?
    Mantis C; Alexopoulos D
    Thromb Res; 2019 Apr; 176():133-139. PubMed ID: 30826397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Triska J; Haddadin F; Madanat L; Jabri A; Daher M; Birnbaum Y; Jneid H
    Cardiovasc Drugs Ther; 2024 Jun; 38(3):605-619. PubMed ID: 35829979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary: Temporarily omitting oral anticoagulants early after stenting for acute coronary syndromes patients with atrial fibrillation.
    Limbruno U; Goette A; De Caterina R
    Int J Cardiol; 2020 Nov; 318():82-85. PubMed ID: 32389765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of dual antithrombotic therapy with direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and metaanalysis of randomized clinical trials.
    Zoppellaro G; Marchese GM; Squizzato A; Denas G; Patti G; De Caterina R; Pengo V
    Intern Emerg Med; 2020 Sep; 15(6):1093-1104. PubMed ID: 32617904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role.
    Alexopoulos D; Vlachakis P; Lekakis J
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):319-324. PubMed ID: 28643219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention.
    Manzi L; Florimonte D; Forzano I; Buongiorno F; Sperandeo L; Castiello DS; Paolillo R; Giugliano G; Giacoppo D; Sciahbasi A; Cirillo P; Esposito G; Gargiulo G
    Interv Cardiol Clin; 2024 Oct; 13(4):527-541. PubMed ID: 39245552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is There a Role for Triple Therapy After ACS?
    Bhogal S; Alkhouli M; White CJ; Bailey S; Mamas M; Haddad E; Paul TK
    Curr Cardiol Rep; 2022 Mar; 24(3):191-200. PubMed ID: 35112242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.
    De Luca L; Di Lenarda A; Rubboli A; Bolognese L; Gonzini L; Fortuni F; Navazio A; Poletti F; Ledda A; Urbinati S; Gabrielli D; Gulizia MM;
    Eur J Intern Med; 2021 Jun; 88():28-34. PubMed ID: 33838988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen.
    Kawakami S; Yasuda S; Ogawa H
    J Cardiol; 2020 Jul; 76(1):35-43. PubMed ID: 32389534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Choi HJ; Lee Y; Park S; Je NK
    Eur J Clin Pharmacol; 2023 Apr; 79(4):541-551. PubMed ID: 36823470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.